Gheuens Sarah
Chief Medical Officer
Gheuens Sarah has filed 8 SEC Form 4 filings (19 transaction rows) across 1 company, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Aug 6, 2026.
Companies traded
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.6M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| AGIO | Chief Medical Officer | Sale | 30,000 | $914K | Aug 6 | SEC ↗ | |
| AGIO | Chief Medical Officer | Sale | 4,007 | $151K | Jul 2 | SEC ↗ | |
| AGIO | Chief Medical Officer | Sale | 2,940 | $102K | Apr 6 | SEC ↗ | |
| AGIO | Chief Medical Officer | Sale | 2,868 | $83K | Mar 3 | SEC ↗ | |
| AGIO | Chief Medical Officer | Sale | 2,932 | $79K | Jan 2 | SEC ↗ | |
| AGIO | Chief Medical Officer | Sale | 2,454 | $107K | Nov 13 | SEC ↗ | |
| AGIO | Chief Medical Officer | Sale | 200 | $9K | Nov 3 | SEC ↗ | |
| AGIO | Chief Medical Officer | Sale | 3,302 | $145K | Oct 29 | SEC ↗ |